APOEε4 drives AD progression through multifactorial mechanisms, including enhanced Aβ aggregation, exacerbated tau pathology, amplified neuroinflammation, and accelerated neuronal degeneration [22,23,24,25,26]. The gene discussed is MAPT; the disease is Alzheimer disease.